Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 16 results for "rozlyn"

TV Cat-fight alert: This actress says Mouni Roy copied her, calls her 'old-fashioned'
DNA

Mouni Roy gives a befitting reply to Model Rozlyn Khan

For latest breaking news, other top stories log on to: http://www.abplive.in ABP Live, 1 week ago

4 images for rozlyn

ABP Live, 1 week ago
ABP Live, 1 week ago
India Glitz, 4 weeks ago
Lake County Record Bee, 1 month ago

Rozlyn Khan's Tweet about Mouni Roy's Golden Costume !

Rachel Zoe had said, Style is a way to say who you are without having to speak and this is so true for celebs in Bollywood and the TV industry as well. The Naagin T.V Serial main lead actress, Mouni Roy has become the ruling Queen of T.V as the ...
 5 Dariya News - English1 week ago

Rozlyn Khan HD images - Picture Gallery

See HD pictures of Rozlyn Khan at our picture gallery...
 Glamsham2 months ago

Hottie Rozlyn Khan goes bold and intense in new de-galm avatar: CHECK OUT!

Hottie Rozlyn Khan has yet again stunned her audience The Queen of sensuality and oomph has gone for a deglam yet bold avatar for the Play Hatak The Insult written by world renowned Saadat Hasan Manto
 India Glitz4 weeks ago

EC nod to Janssen's TREVICTA® 3‑month...

The European Commission (EC) has approved the use of Janssen's TREVICTA® (paliperidone palmitate, a 3‑monthly injection) for the maintenance treatment of schizophrenia. The paliperidone palmitate injection will provide the longest dosing ...
 Pharma Field1 week ago European Commission approves TREVICTA (paliperidone palmitate 3-monthly injection), for schizophrenia  Medical News Today3 weeks ago
Pharmafile

Janssen says Imbruvica shows improved PFS in blood cancer in long-term effectiveness study

Janssen said late-stage studies to test long-term effectiveness for its Imbruvica (ibrutinib) in blood cancer showed improved progression free survival of 74.8%. The company said the drug to treat Chronic Lymphocytic Leukaemia (CLL) and mantle ...
 Pharmafile1 week ago

Janssen says its immunotherapy daratumumab extends progression-free survival in combination study to treat multiple myeloma

Janssen said late-stage combination trials for its immunotherapy daratumumab increased progression-free survival for patients with multiple myeloma. The company said the Phase III study for the drug in combination with lenalidomide (an ...
 Pharmafile2 weeks ago

Involuntary Terminations: Indiana

Involuntary Terminations requirements for other states Federal law and guidance on this subject should be reviewed together with this section. Authors: Stuart R. Buttrick , Rozlyn Fulgoni-Britton and Susan W. Kline , Faegre Baker Daniels LLP ...
 XpertHR2 weeks ago

Child Labor: Iowa

Child Labor requirements for other states Federal law and guidance on this subject should be reviewed together with this section. Authors: Stuart R. Buttrick , Susan W. Kline and Rozlyn Fulgoni-Britton , Faegre Baker Daniels, LLP Summary ...
 XpertHR1 month ago

Law Breaking Hotties

Simran Sood : Last month, the small-time model was accused of being involved in the kidnapping and killing of 28-year-old Delhi resident Karan Kumar Kakkad. Reportedly, she was acting as a honey trap to lure wealthy men. Sood's connection has ...
 FHM India1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
Happening by Location Click on any location on map to view latest news by location
 
More     Less